Saturday, April 25, 2015 11:09:00 AM
the shorts gotta eat too.
I've said from the beginning that this is not a "pot play".
This is a pure, unadulterated, full fledged pharmaceutical company on the cutting edge of modern medicine.
People don't understand that GW has been at this for a decade. Hundreds of patents and multitudes of pages of published clinical trial research.
Otsuka funded Sativex, but we shareholders funded Epidolex.
Sativex pays big pharm.
Epidolex will pay us.
Just wait for those two little words to come from the FDA......
"fast track"
and just look what else they have in store for the next decade.
$GWPH
"The aim of the wise is not to secure pleasure, but to avoid pain."
-Aristotle
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM